SCHEMBL26036244

SCHEMBL26036244

CCc1ccc(-c2cc(OC)c(CC)c(OC)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 1/20 0.45
PTGS2 P35354 2/20 0.44
ERN1 O75460 3/20 0.42
CA2 P00918 2/20 0.39
HSD17B10 Q99714 2/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TLR9 Q9NR96 1/20 0.39
TLR8 Q9NR97 1/20 0.39
TLR7 Q9NYK1 1/20 0.39
ALOX5 P09917 1/20 0.38
PTGS1 P23219 1/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
CSNK2A1 P68400 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
CA12 O43570 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26036259 1.00 TUBB1 (0.45) TUBB1PTGS2ERN1CA2HSD17B10
SCHEMBL1687448 0.82 CA2 (0.55) TUBB1PTGS2CA2HSD17B10ALDH1A1
SCHEMBL26036242 0.79 HSD17B10 (0.44) TUBB1PTGS2ERN1HSD17B10ALDH1A1
SCHEMBL26036254 0.79 HSD17B10 (0.44) TUBB1PTGS2ERN1HSD17B10ALDH1A1
SCHEMBL26036253 0.79 HSD17B10 (0.44) TUBB1PTGS2ERN1HSD17B10ALDH1A1
SCHEMBL16158575 0.78 ALOX5 (0.58) PTGS2ALDH1A1CYP3A4TSHRTDP1
SCHEMBL18666412 0.78 CYP17A1 (0.49) TUBB1PTGS2HSD17B10ALDH1A1CYP3A4
SCHEMBL19423242 0.76 RXRA (0.48) CA2ALDH1A1
SCHEMBL13674501 0.76 MAOB (0.55) CA2HSD17B10ALDH1A1CYP3A4TSHR
SCHEMBL18666696 0.76 HTT (0.52) TUBB1PTGS2CA2ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11739270-B2 Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound DIC CORPORATION (JP) 2023-08-29 US disclosed
US-20230131540-A1 LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY ELEMENT AND COMPOUND DIC CORPORATION (JP) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11739270-B2 Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound OCIAD2, PKN2, SKP1 TUBB1 2263/4885PTGS2 3011/4885ERN1 805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.